Dr Paul Collini
Prof David Kiely
Dr Thomas Darton
Senior Clinical Lecturer and Honorary Consultant in Infectious Diseases
The CRF/Vaccine Team have been incredible throughout the COVID 19 pandemic. The team, led by Jayne Willson, have consolidated their national and international reputation for their ability and professionalism in participant recruitment, safe vaccine administration and active surveillance during the follow-up period. This is reflected in the statistics as a leading national recruiter to multiple studies, contribution to numerous high-impact publications and resulting policy recommendations, by feedback from CROs and sponsors, and by the ongoing enthusiasm and positive feedback from participants taking part in the research.
Supported by the CRF, the contribution made to numerous COVID vaccine studies (COV002, COV009, ENSEMBLE2, Moderna Bivalent, AZ Omicron study, COMCOV2, etc) has resulted in the formation of evidence-based public health policy for mitigating the impact of the 2019 COVID pandemic. Ongoing work is leading to a pivotal phase 3 E.coli vaccine study (E.mbrace), the commencement of early phase studies, including FIH/Phase 1 and vaccine/challenge studies. Due to the contributions of the CRF, Sheffield is fast becoming an national centre of excellence in the delivery of vaccine research.
Have you used the CRF to deliver your research?
Please take a moment to give us your feedback on our service so that we can be sure to provide high quality support in the way that you need us.
It will only take a few moments of your time and the information you provide will be used to improve our current service and to shape the service of the future, making sure that we can support your research in the way you need us.